Recruiting Clinical Trials

Displaying 1 - 10 of 174 result(s)
Study Title Condition Phase Location
Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2)
  • Myelodysplastic Syndromes
  • Leukemia, Myelomonocytic, Chronic
  • Phase 3
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Austria
  • Country: 
Assessing the Impact of Lipoprotein (a) Lowering With TQJ230 on Major Cardiovascular Events in Patients With CVD
  • Cardiovascular Disease and Lipoprotein(a)
  • Phase 3
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Austria
  • Country: 
Efficacy and Safety of Acetylcysteine for the Treatment of Acute Uncomplicated Rhinosinusitis
  • Rhinosinusitis
  • Phase 3
  • Country: 
    Bulgaria
  • Country: 
    Germany
  • Country: 
    Moldova, Republic of
  • Country: 
Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
  • CML
  • Chronic Myelogenous Leukemia
  • Leukemia, Myeloid Chronic
  • Hematologic Diseases
  • Phase 2
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Austria
  • Country: 
A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis
  • Relapsing Multiple Sclerosis
  • Phase 3
  • Country: 
    United States
Lipoprotein(a) in Patients With Cardiovascular Disease (CVD)
  • Cardiovascular Disease and Lipoprotein(a)
  • Not Applicable
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Australia
  • Country: 
Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs
  • Chronic Myelogenous Leukemia
  • Phase 3
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Australia
  • Country: 
Retrospective Chart Review Study of Patients With PIK3CA-Related Overgrowth Spectrum Who Have Received Alpelisib
  • PIK3CA-Related Overgrowth Spectrum (PROS)
  • Not Given
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    France
  • Country: 
Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D
  • Heart Failure
  • Phase 4
  • Country: 
    China
ADCC Mediated B-Cell dEpletion and BAFF-R Blockade
  • Autoimmune Hepatitis
  • Phase 2
  • Phase 3
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Belgium
  • Country: